Page last updated: 2024-08-07 17:09:36
Neuropeptide Y receptor type 5
A neuropeptide Y receptor type 5 that is encoded in the genome of human. [PRO:WCB, UniProtKB:Q15761]
Synonyms
NPY5-R;
NPY-Y5 receptor;
NPYY5-R;
Y5 receptor
Research
Bioassay Publications (12)
Timeframe | Studies on this Protein(%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (8.33) | 18.2507 |
2000's | 7 (58.33) | 29.6817 |
2010's | 4 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Compounds (8)
Drugs with Inhibition Measurements
Drug | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Publication(s) |
---|---|---|---|---|---|
benextramine | Homo sapiens (human) | Ki | 5.0000 | 1 | 1 |
bibp 3226 | Homo sapiens (human) | Ki | 10.0000 | 1 | 1 |
cgp 71683 a | Homo sapiens (human) | IC50 | 0.0025 | 4 | 4 |
n-(4-((4-(dimethylamino)quinazolin-2-yl)amino)cyclohexyl)-3,4-difluorobenzamide hydrochloride | Homo sapiens (human) | IC50 | 2.7000 | 1 | 1 |
mk-0557 | Homo sapiens (human) | IC50 | 0.0013 | 2 | 2 |
mk-0557 | Homo sapiens (human) | Ki | 0.0016 | 1 | 1 |
neuropeptide y (24-36) amide, n-acetyl-(leu(28,31))- | Homo sapiens (human) | Ki | 1.0000 | 2 | 2 |
lu aa33810 | Homo sapiens (human) | IC50 | 0.0018 | 1 | 1 |
lu aa33810 | Homo sapiens (human) | Ki | 0.0015 | 1 | 1 |
Drugs with Other Measurements
Drug | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Publication(s) |
---|---|---|---|---|---|
bms 193885 | Homo sapiens (human) | Kb | 1.0000 | 1 | 1 |
Enables
This protein enables 4 target(s):
Target | Category | Definition |
---|---|---|
neuropeptide Y receptor activity | molecular function | Combining with neuropeptide Y to initiate a change in cell activity. [PMID:9315606] |
pancreatic polypeptide receptor activity | molecular function | Combining with pancreatic polypeptide PP to initiate a change in cell activity. [PMID:9315606] |
peptide YY receptor activity | molecular function | Combining with gut peptide YY to initiate a change in cell activity. [PMID:9315606] |
neuropeptide binding | molecular function | Interacting selectively and non-covalently and stoichiometrically with neuropeptides, peptides with direct synaptic effects (peptide neurotransmitters) or indirect modulatory effects on the nervous system (peptide neuromodulators). [http://www.wormbook.org/chapters/www_neuropeptides/neuropeptides.html] |
Located In
This protein is located in 3 target(s):
Target | Category | Definition |
---|---|---|
plasma membrane | cellular component | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. [ISBN:0716731363] |
presynapse | cellular component | The part of a synapse that is part of the presynaptic cell. [GOC:dos] |
GABA-ergic synapse | cellular component | A synapse that uses GABA as a neurotransmitter. These synapses are typically inhibitory. [GOC:dos] |
Active In
This protein is active in 2 target(s):
Target | Category | Definition |
---|---|---|
plasma membrane | cellular component | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. [ISBN:0716731363] |
neuron projection | cellular component | A prolongation or process extending from a nerve cell, e.g. an axon or dendrite. [GOC:jl, http://www.cogsci.princeton.edu/~wn/] |
Involved In
This protein is involved in 15 target(s):
Target | Category | Definition |
---|---|---|
positive regulation of acute inflammatory response | biological process | Any process that activates or increases the frequency, rate, or extent of an acute inflammatory response. [GOC:add] |
negative regulation of acute inflammatory response to antigenic stimulus | biological process | Any process that stops, prevents, or reduces the frequency, rate, or extent of an acute inflammatory response to an antigenic stimulus. [GOC:add] |
outflow tract morphogenesis | biological process | The process in which the anatomical structures of the outflow tract are generated and organized. The outflow tract is the portion of the heart through which blood flows into the arteries. [GOC:mtg_heart, UBERON:0004145] |
cardiac left ventricle morphogenesis | biological process | The process in which the left cardiac ventricle is generated and organized. [GOC:mtg_heart] |
neuropeptide signaling pathway | biological process | A G protein-coupled receptor signaling pathway initiated by a neuropeptide binding to its receptor on the surface of a target cell, and ending with the regulation of a downstream cellular process. [GOC:mah, ISBN:0815316194] |
negative regulation of glutamate secretion | biological process | Any process that stops, prevents, or reduces the frequency, rate or extent of the controlled release of glutamate. [GOC:ef] |
negative regulation of synaptic transmission, GABAergic | biological process | Any process that stops, prevents, or reduces the frequency, rate or extent of GABAergic synaptic transmission, the process of communication from a neuron to another neuron across a synapse using the neurotransmitter gamma-aminobutyric acid (GABA). [GOC:mah] |
eating behavior | biological process | The specific behavior of an organism relating to the intake of food, any substance (usually solid) that can be metabolized by an organism to give energy and build tissue. [GOC:jl, GOC:pr, PMID:19361967] |
negative regulation of apoptotic process | biological process | Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process. [GOC:jl, GOC:mtg_apoptosis] |
positive regulation of smooth muscle cell proliferation | biological process | Any process that activates or increases the rate or extent of smooth muscle cell proliferation. [CL:0000192, GOC:ebc] |
generation of ovulation cycle rhythm | biological process | The process which controls the timing of the type of sexual cycle seen in female mammals. [GOC:dph] |
positive regulation of ERK1 and ERK2 cascade | biological process | Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade. [GOC:mah] |
synaptic signaling via neuropeptide | biological process | Cell-cell signaling to or from a synapse, mediated by a peptide. [GOC:dos] |
chemical synaptic transmission | biological process | The vesicular release of classical neurotransmitter molecules from a presynapse, across a chemical synapse, the subsequent activation of neurotransmitter receptors at the postsynapse of a target cell (neuron, muscle, or secretory cell) and the effects of this activation on the postsynaptic membrane potential and ionic composition of the postsynaptic cytosol. This process encompasses both spontaneous and evoked release of neurotransmitter and all parts of synaptic vesicle exocytosis. Evoked transmission starts with the arrival of an action potential at the presynapse. [GOC:jl, MeSH:D009435] |
G protein-coupled receptor signaling pathway | biological process | The series of molecular signals initiated by a ligand binding to its receptor, in which the activated receptor promotes the exchange of GDP for GTP on the alpha-subunit of an associated heterotrimeric G-protein complex. The GTP-bound activated alpha-G-protein then dissociates from the beta- and gamma-subunits to further transmit the signal within the cell. The pathway begins with receptor-ligand interaction, and ends with regulation of a downstream cellular process. The pathway can start from the plasma membrane, Golgi or nuclear membrane. [GOC:bf, GOC:mah, PMID:16902576, PMID:24568158, Wikipedia:G_protein-coupled_receptor] |